{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:56:29Z","timestamp":1765486589121,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.aprim.2021.102041","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:34:41Z","timestamp":1616805281000},"page":"102041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Calidad de vida relacionada con la salud en pacientes consumidores de benzodiacepinas"],"prefix":"10.1016","volume":"53","author":[{"given":"Eva Mar\u00eda","family":"Garc\u00eda Atienza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"L\u00f3pez-Torres Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Minuesa Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Ruip\u00e9rez Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Lucas Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Agudo Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2021.102041_bib0165","first-page":"508","article-title":"Health-related quality of life in caregivers of patients with Alzheimer disease","volume":"32","author":"Garz\u00f3n Maldonado","year":"2017","journal-title":"Neurolog\u00eda."},{"key":"10.1016\/j.aprim.2021.102041_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1575-0973(07)75635-0","article-title":"Test para la Evaluaci\u00f3n de la Calidad de Vida en Adictos a Sustancias Psicoactivas (TECVASP): estudios de fiabilidad y validez","volume":"9","author":"Lozano Rojas","year":"2007","journal-title":"Trastornos Adictivos."},{"key":"10.1016\/j.aprim.2021.102041_bib0175","first-page":"505","article-title":"Health-related quality of life as an outcome measure in patients with ischemic cardiopathy","volume":"11","author":"Soto","year":"2004","journal-title":"Rev Soc Esp Dolor."},{"key":"10.1016\/j.aprim.2021.102041_bib0180","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jama.1994.03520220035028","article-title":"Common mental disorders and disability across cultures. Results from the WHO collaborative study on psychological problems in general health care","volume":"272","author":"Ormel","year":"1994","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2021.102041_bib0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0212-6567(03)70658-1","article-title":"Prevalencia de psicopat\u00edas en un centro de salud rural","volume":"31","author":"Mart\u00edn P\u00e9rez","year":"2003","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4321\/S1137-66272007000200011","article-title":"El insomnio","volume":"30","author":"Sarrais","year":"2007","journal-title":"An Sist Sanit Navar."},{"key":"10.1016\/j.aprim.2021.102041_bib0195","first-page":"637","article-title":"El papel de la depresi\u00f3n, la ansiedad, el estr\u00e9s y la adhesi\u00f3n al tratamiento en la calidad de vida relacionada con la salud en pacientes en di\u00e1lisis: revisi\u00f3n sistem\u00e1tica de la literatura","volume":"34","author":"Garc\u00eda Llana","year":"2014","journal-title":"Nefrologia."},{"key":"10.1016\/j.aprim.2021.102041_bib0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.aprim.2016.03.004","article-title":"Quality of life, sleepiness and depressive symptoms in adolescents with insomnia: A cross-sectional study","volume":"49","author":"Pereira Amaral","year":"2017","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0205","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4321\/S1135-57272013000300004","article-title":"Evoluci\u00f3n del uso de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a durante el per\u00edodo 2000-2011","volume":"87","author":"Vicente S\u00e1nchez","year":"2013","journal-title":"Rev Esp Salud P\u00fablica."},{"key":"10.1016\/j.aprim.2021.102041_bib0210","first-page":"1","article-title":"Estrategias en la retirada de Benzodiacepinas: otras alternativas. Bolet\u00edn F\u00e1rmaco-terap\u00e9utico de Castilla-La Mancha","volume":"13","author":"Mart\u00ednez Garc\u00eda","year":"2012","journal-title":"Sescam."},{"key":"10.1016\/j.aprim.2021.102041_bib0215","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios AEMPS. Utilizaci\u00f3n de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a durante el periodo 2010-2018. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2019 [consultado 10 Oct 2020]. Disponible en: https:\/\/www.aemps.gob.es\/eu\/medicamentosUsoHumano\/observatorio\/informes-publicados\/informes-ansioliticos-hipnoticos-espana-2010-2018.htm"},{"key":"10.1016\/j.aprim.2021.102041_bib0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3399\/bjgp09X420923","article-title":"Variations in anxiolytic and hypnotic prescribing by GPs: A cross-sectional analysis using data from the UK Quality and Outcomes Framework","volume":"59","author":"Tsimtsiou","year":"2009","journal-title":"Br J Gen Pract."},{"key":"10.1016\/j.aprim.2021.102041_bib0225","first-page":"79","article-title":"La versi\u00f3n espa\u00f1ola del EuroQol: descripci\u00f3n y aplicaciones","volume":"112","author":"Bad\u00eda","year":"1999","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.aprim.2021.102041_bib0230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0212-6567(01)70406-4","article-title":"El EuroQol-5D: una alternativa sencilla para la medici\u00f3n de la calidad de vida relacionada con la salud en atenci\u00f3n primaria","volume":"28","author":"Herdman","year":"2001","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4321\/S1135-57272015000200009","article-title":"Impacto del tratamiento con teriparatida en la calidad de vida de las personas con osteoporosis","volume":"89","author":"Osca Guadalajara","year":"2015","journal-title":"Rev Esp Salud P\u00fablica."},{"key":"10.1016\/j.aprim.2021.102041_bib0240","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.aprim.2008.10.019","article-title":"La calidad de vida relacionada con la salud","volume":"41","author":"Liz\u00e1n Tudela","year":"2009","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0245","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.297.6653.897","article-title":"Detecting anxiety and depression in general medical settings","volume":"297","author":"Goldberg","year":"1988","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2021.102041_bib0250","first-page":"345","article-title":"Escalas de ansiedad y depresi\u00f3n de Goldberg: una gu\u00eda de entrevista eficaz para la detecci\u00f3n del malestar ps\u00edquico","volume":"12","author":"Mont\u00f3n","year":"1993","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0255","first-page":"34","article-title":"Estudio de validaci\u00f3n de la traducci\u00f3n al espa\u00f1ol de la Escala Atenas de Insomnio","volume":"28","author":"Nenclares","year":"2005","journal-title":"Salud Mental."},{"key":"10.1016\/j.aprim.2021.102041_bib0260","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0212-6567(08)75695-6","article-title":"Elevado consumo de benzodiacepinas en mujeres ancianas asignadas a centros de salud urbanos de atenci\u00f3n primaria","volume":"40","author":"Bejarano Romero","year":"2008","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.aprim.2011.07.018","article-title":"Suitability of the use of benzodiazepines prescribed by the pharmacist in the elderly. A doctor-pharmacist collaboration study","volume":"44","author":"Velert Vila","year":"2012","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1157\/13079144","article-title":"Estudio de utilizaci\u00f3n de psicof\u00e1rmacos en atenci\u00f3n primaria","volume":"36","author":"Vedia Urgell","year":"2005","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0212-6567(00)78472-1","article-title":"Prescripci\u00f3n de benzodiacepinas en un centro de salud: prevalencia, c\u00f3mo es su consumo y caracter\u00edsticas del consumidor","volume":"25","author":"Escriv\u00e1 Ferrair\u00f3","year":"2000","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0280","unstructured":"Ministerio de Sanidad y Consumo. Gu\u00eda de Prescripci\u00f3n Terap\u00e9utica (GPT). Adaptaci\u00f3n espa\u00f1ola de la 51.\u00aa ed. del British National Formulary (BNF), 1.\u00aao ed. espa\u00f1ola. Barcelona: Pharma Editores S.L.; 2006."},{"key":"10.1016\/j.aprim.2021.102041_bib0285","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios AEMPS. Circular 3\/2000: Informaci\u00f3n a incluir en las fichas t\u00e9cnicas de especialidades farmac\u00e9uticas que contengan benzodiazepinas. Ministerio de Sanidad y Consumo; 20\/03\/2000 [consultado 10 Oct 2020]. Disponible en: https:\/\/www.aemps.gob.es\/informa\/circulares\/medicamentosUsoHumano\/seguridad\/2000\/home.htm"},{"key":"10.1016\/j.aprim.2021.102041_bib0290","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.gaceta.2015.08.007","article-title":"El EQ-5D como medida de resultados en salud","volume":"29","author":"Cabas\u00e9s","year":"2015","journal-title":"Gac Sanit."},{"key":"10.1016\/j.aprim.2021.102041_bib0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0212-6567(03)79180-X","article-title":"Calidad de vida en mayores de 65 a\u00f1os no institucionalizados de dos \u00e1reas sanitarias de Madrid","volume":"31","author":"Azpiazu Garrido","year":"2003","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2021.102041_bib0300","doi-asserted-by":"crossref","unstructured":"Szende A, Janssen B. Cross-country analysis of EQ-5D data. En: Szende A, Janssen B, Carbaes J, editores. Self-reported population health: An international perspective based on EQ-5D. Dordrecht: Springer; 2014. p. 31-36.","DOI":"10.1007\/978-94-007-7596-1_4"},{"key":"10.1016\/j.aprim.2021.102041_bib0305","first-page":"91","article-title":"An\u00e1lisis de la comorbilidad y calidad de vida de pacientes mayores polimedicados","volume":"9","author":"Hern\u00e1ndez Cer\u00f3n","year":"2016","journal-title":"Rev Cl\u00edn Med Fam."},{"key":"10.1016\/j.aprim.2021.102041_bib0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4321\/S1135-57272015000100007","article-title":"Calidad de vida relacionada con la salud como variable explicativa del consumo de consultas en atenci\u00f3n primaria: un an\u00e1lisis por sexo","volume":"89","author":"Pariente Rodrigo","year":"2015","journal-title":"Rev Esp Salud Publica."},{"key":"10.1016\/j.aprim.2021.102041_bib0315","unstructured":"Margolles M, Donate. I Encuesta de Salud para Asturias 2008. Direcci\u00f3n General de Salud P\u00fablica y Participaci\u00f3n. 2009 [consultado 5 Oct 2020]. Disponible en: https:\/\/www.astursalud.es\/documents\/31867\/36150\/3_calidadvida_I.pdf\/180237de-9600-4806-8995-0b3e66e936ca"},{"key":"10.1016\/j.aprim.2021.102041_bib0320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12877-020-01838-8","article-title":"Health-related quality of life in hospitalized older patients with versus without prolonged use of opioid analgesics, benzodiazepines, and z-hypnotics: A cross-sectional study","volume":"20","author":"Cheng","year":"2020","journal-title":"BMC Geriatrics."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656721000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656721000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:00:05Z","timestamp":1759323605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656721000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0212656721000755"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2021.102041","relation":{},"ISSN":["0212-6567"],"issn-type":[{"type":"print","value":"0212-6567"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calidad de vida relacionada con la salud en pacientes consumidores de benzodiacepinas","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2021.102041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102041"}}